Pill power: new drug combo may ease sleep apnea without a mask
NCT ID NCT03919955
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study tested a combination of two drugs, atomoxetine and oxybutynin (called AtoOxy), as a potential pill-based treatment for obstructive sleep apnea (OSA). 117 adults with OSA who were not using CPAP took the medication for one month. The goal was to see if the drug combo could reduce breathing pauses during sleep and improve daytime sleepiness, and to identify which patients benefit most.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Do current sleepiness tests work for kids? a new study puts them to the test
- Remote monitoring may boost sleep apnea therapy adherence
- Could a mouthpiece replace the CPAP machine for sleep apnea?
- Can a new painkiller prevent breathing crises after surgery?
- Personalizing sleep apnea treatment: a step toward better CPAP outcomes
- A blood test for sleep apnea? MicroRNAs may hold the key